Registered entities
Innovation
26 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 528 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 11 |
| 2024 | 18 |
| 2025 | 8 |
Investor mix
14 investors on record; lead investors include Versant Ventures, New Enterprise Associates, Aisling Capital, Avoro Capital; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 64% |
| Private equity | 2 | 14% |
| Other / undisclosed | 3 | 21% |
Hiring activity
Hires periodically
4 roles tracked across 3 of the last 12 months
10 Jun 2026 · Director, Drug Safety & Pharmacovigilance (Inflammation & Oncology) · Boston
31 Mar 2026 · Manager, Regulatory Affairs Associate · Boston
2 Mar 2026 · Project Lead - Program Management Solutions Integration (6 Month) · Boston
4 Dec 2025 · Global Office Operations & Exec Support Lead · Boston
4 May 2025 · CONTRACTOR - HUMAN RESOURCES ASSOCIATE (6 MONTH CONTRACT) · Boston
Based on job postings tracked across public sources.